Skip to content

Management of age-related conditions is 'the future of HIV care', says IAS conference keynote speaker

Steven Deeks of the University of California San Francisco gives the keynote address at IAS 2013. Photo ©International AIDS Society/Marcus Rose/Workers' Photos

New pro-drug tenofovir alafenamide appears equally effective but better tolerated

Andrew Zolopa, Stamford University, presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Frailty increases the risk of fragility fractures in men living with HIV: data collected in routine HIV care can help predict risk

Co-infection with hepatitis B or C is a risk factor for reduced bone mineral density among women with HIV

Dutch find low bone mineral density in gay men, regardless of HIV infection status

Low bone density present in young men taking HIV therapy

HIV/hepatitis C co-infection increases risk of hip fracture

HIV treatment reduces risk of fractures

Vitamin D supplements benefit bone metabolism of younger patients taking tenofovir